Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
23.05. | Biovica International: New DiviTum TKa Data to be Presented at ASCO in Three Cancer Types | 236 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / May 23, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, active in cancer monitoring, today announces that three abstracts based on studies... ► Artikel lesen | |
19.05. | Biovica International: Biovica Signs Major Service Agreement and First Study Work Order of 4 MSEK | 210 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / May 19, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announces the signing of a Master... ► Artikel lesen | |
13.05. | Biovica International: Biovica Collaborates with Tempus to Expand the Commercial Reach of DiviTum TKa | 366 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / May 13, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, has entered a reference lab agreement... ► Artikel lesen | |
26.03. | Biovica International: DiviTum TKa Data in Combination with Inflammation Proteins Presented at the AACR Meeting Enhance Precision to Predict Efficacy of Immunotherapy | 329 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / March 26, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, a leader in blood-based biomarker assays in oncology, today announces that an abstract... ► Artikel lesen | |
BIOVICA INTERNATIONAL Aktie jetzt für 0€ handeln | |||||
13.03. | Biovica International AB receives observation status | 112 | GlobeNewswire | Today, March 13, 2025, Biovica International AB (the "Company") disclosed its financial report for the period November 2024 - January 2025 with information on the Company's financial situation.
The... ► Artikel lesen | |
13.03. | Biovica International: Biovica Q3 Interim report Nov 2024 - Jan 2025 | 276 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / March 13, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Quarterly sales doubled, expanding market potential exponentiallySEK tQ3 24/25Q3 23/24May-Jan... ► Artikel lesen | |
12.03. | Biovica International: Biovica and Outcomes4Me Partner to Support Metastatic Breast Cancer Patients to Better Understand the Effectiveness of their Treatment | 311 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / March 12, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Today, Biovica, a leader in blood-based cancer monitoring, announces a partnership with... ► Artikel lesen | |
10.03. | Biovica International: Biovica Signs New Work Order with US Biotech Company for TKa Testing Services | 243 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / March 10, 2025 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in blood-based cancer monitoring, has secured a new work order (WO) valued... ► Artikel lesen | |
05.03. | Biovica International: Biovica Signs Agreement With Eurobio Scientific Covering 60 Percent of European Market | 390 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / March 5, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, has signed a collaboration agreement with Eurobio Scientific... ► Artikel lesen | |
06.02. | Biovica International: Board Member of Biovica Resigns at Own Request | 277 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / February 6, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica today announces that board member Ulf Jungnelius has resigned from the board at... ► Artikel lesen | |
06.02. | Nomination Committee for Biovica International AB for the 2025 Annual General Meeting | 260 | ACCESS Newswire | UPPSALA, SE / ACCESS Newswire / February 6, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) The Nomination Committee prior to the 2025 Annual General Meeting will consist of three... ► Artikel lesen | |
13.01. | Biovica International: Biovica Secures Major Work Order for TKa Testing Services | 269 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / January 13, 2025 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in blood-based cancer monitoring, has signed an order with a total value of... ► Artikel lesen | |
12.12.24 | Biovica International: Agreement Signed with US Insurance Giant and Expanded Market | 274 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / December 12, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)SEK tQ2 24/25Q2 23/24May-Oct 24/25May-Oct 23/24Full year 23/24Net sales2,3122,5634,0274,3167... ► Artikel lesen | |
06.12.24 | Biovica International: Biovica CLIA Lab Achieves New York State Permit that Opens the Entire US Market | 261 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / December 06, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Biovica, active in blood-based cancer monitoring, today announces that the company has obtained... ► Artikel lesen | |
02.12.24 | Biovica International: Biovica Signs Agreement with American Health Giant | 335 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / December 02, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Biovica, active in blood-based cancer monitoring, today announces that the company has entered... ► Artikel lesen | |
26.11.24 | Biovica International: New DiviTum TKa data to be Presented at SABCS that Significantly Broaden the Addressable Market | 384 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / November 26, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B) (FRA:9II) Biovica, active in cancer monitoring, announces that seven abstracts based on studies using... ► Artikel lesen | |
22.10.24 | Biovica International: Biovica signs agreement with UK biotech company | 239 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / October 22, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in blood-based cancer monitoring, has signed a Master Service Agreement (MSA)... ► Artikel lesen | |
03.10.24 | Biovica International: Biovica Announces Outcome of Exercise of Warrants of Series To 3 B | 415 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / October 3, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica International AB ("Biovica" or the "Company") announces today the outcome of the... ► Artikel lesen | |
24.09.24 | Biovica International: Biovica Announces Subscription Commitments in Ongoing TO3B Program | 239 | ACCESS Newswire | UPPSALA, SWEDEN / ACCESSWIRE / September 24, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Monday, September 30, 2024, is the last day for subscription in Biovica's ongoing warrant... ► Artikel lesen | |
23.09.24 | Biovica International: Biovica Signs Significant Work Order for TKa Testing Services | 306 | ACCESS Newswire | UPPSALA, SE / ACCESSWIRE / September 23, 2024 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in blood-based cancer monitoring, has signed a work order with a value of... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BIONTECH | 95,35 | +0,05 % | Summit Therapeutics crasht - BioNTech in Sippenhaft | Wie gewonnen, so zerronnen: Die Aktie von Summit Therapeutics brach am vergangenen Freitag an der Nasdaq um rund 30 Prozent ein. Weitere Studiendaten zum großen Hoffnungsträger Ivonescimab, den die... ► Artikel lesen | |
EVOTEC | 7,060 | +0,94 % | Evotec Aktie: Ohne Übernahme sieht es schlecht aus! Auf diese Kursmarke kommt es an! | © Foto: Finanznachrichten (Symbolbild)Zwischen Kursrakete mit Übernahmefantasie und Korrekturmodus Richtung Süden. Der Biotech-Titel aus Hamburg liefert seit Wochen ein Wechselbad der Gefühle. Kann... ► Artikel lesen | |
BB BIOTECH | 32,850 | +0,77 % | BB Biotech - Optimistic about biotech's long-term prospects | During 2024 and early this year, the biotech sector began to show signs of a structural recovery, supported by positive clinical data, regulatory approvals, lower interest rates, commercial execution... ► Artikel lesen | |
CUREVAC | 3,830 | -0,83 % | Kauf-Alarm bei CureVac: Insider decken sich massenhaft mit Aktien ein - Unbedingt beachten wegen Montag! | ||
MODERNA | 23,805 | +1,08 % | BioNTech-Konkurrent Moderna: Erst Enttäuschung, jetzt Freude - das ist der Grund | Aktionäre von Moderna hatten in den vergangenen Monaten kaum Anlass zur Freude. Eine Hiobsbotschaft nach der anderen sorgte für immer tiefer fallende Kurse. Auch Ende vergangener Woche gab es erneut... ► Artikel lesen | |
PAION | 0,025 | +9,73 % | Unglaubliche Prognose für Montag setzt Paion Aktionäre unter Druck. Jetzt Sondermeldung lesen und Montag reagieren! | ||
VALNEVA | 2,732 | -0,15 % | Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy | Original-Research: Valneva SE - von First Berlin Equity Research GmbH 03.06.2025 / 14:27 CET/CEST Veröffentlichung einer Research, übermittelt durch EQS News - ein Service der EQS Group. Für den... ► Artikel lesen | |
EPIGENOMICS | 0,880 | 0,00 % | EQS-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Epigenomics AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Epigenomics AG: Vorabbekanntmachung über die... ► Artikel lesen | |
NOVAVAX | 6,520 | -0,20 % | Aktien New York: Rücksetzer nach US-Bonitätsabstufung verpufft | NEW YORK (dpa-AFX) - Die Abstufung der US-Kreditwürdigkeit durch Moody?s hat die Anleger in New York am Montag nicht lange beeindruckt. Benoit Anne, Anleiheexperte bei MFS Investment Management, verwies... ► Artikel lesen | |
STRYKER | 337,40 | +0,12 % | Former Intuitive, Stryker VP joins Think Surgical as EVP to advance surgical robot tech | ||
BIOFRONTERA | 2,500 | 0,00 % | Biofrontera sichert Patent für Ameluz-Formulierung bis 2043 | ||
BIOGEN | 116,70 | -0,09 % | DAX tritt auf der Stelle - Nvidia & Biogen mit Überraschung! Gold, EUR & Aktien im Chartcheck | ||
ILLUMINA | 72,45 | -0,10 % | Does Illumina (ILMN) Have Good Long-Term Growth Prospects? | ||
4SC | 1,200 | +4,35 % | PTA-News: 4SC AG: Resminostat (Kinselby) negative Empfehlung des CHMP in der EU erhalten | DJ PTA-News: 4SC AG: Resminostat (Kinselby) negative Empfehlung des CHMP in der EU erhalten
Unternehmensmitteilung für den Kapitalmarkt
4SC AG: Resminostat (Kinselby) negative Empfehlung... ► Artikel lesen | |
NANOREPRO | 1,675 | -1,18 % | EQS-DD: NanoRepro AG: Dr. Olaf Stiller, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
26.05.2025 / 14:00... ► Artikel lesen |